• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

下肢动脉疾病股总动脉血栓内膜切除术的临床结果:慢性肢体威胁性缺血与间歇性跛行之间的差异

Clinical Outcomes of Common Femoral Thromboendarterectomy for Lower-Extremity Arterial Disease: Differences Between Chronic Limb-Threatening Ischemia and Intermittent Claudication.

作者信息

Mizoguchi Takahiro, Harada Takasuke, Takeuchi Yuriko, Samura Makoto, Kurazumi Hiroshi, Suzuki Ryo, Suehiro Kotaro, Hamano Kimikazu

机构信息

Division of Vascular Surgery, Department of Surgery and Clinical Science, Yamaguchi University Graduate School of Medicine, Yamaguchi, Japan.

出版信息

Vasc Specialist Int. 2025 Jul 31;41:18. doi: 10.5758/vsi.250027.

DOI:10.5758/vsi.250027
PMID:40739708
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12311306/
Abstract

PURPOSE

This study retrospectively evaluated the mid-term outcomes of thromboendarterectomy (TEA) for common femoral artery (CFA) disease in a Japanese cohort by comparing patients with chronic limb-threatening ischemia (CLTI) and intermittent claudication (IC).

MATERIALS AND METHODS

Sixty-three TEA procedures performed between 2011 and 2024 were analyzed. The primary endpoints focused on procedure-related outcomes such as patency and limb salvage, whereas overall survival was assessed as a key secondary outcome. The patients were divided into the CLTI (n=20) and IC (n=43) groups; the anesthesia type, additional revascularization, blood loss, hospital stay, complications, and survival were compared. Multivariable Cox regression analysis was performed to identify independent predictors of mortality.

RESULTS

Patients with CLTI had higher rates of local anesthesia, additional revascularization (all performed concomitantly), greater blood loss, and longer hospital stays. Despite the 100% technical success in both groups, 30-day mortality and complications occurred only in the CLTI group. Kaplan-Meier analysis showed similar patency and limb salvage rates between groups, whereas survival rates were significantly lower in patients with CLTI (P=0.037). Multivariable analysis revealed that CLTI itself was not an independent predictor of mortality; rather, a worse systemic status (e.g., higher American Society of Anesthesiologists classification) showed a trend toward poorer outcomes (P=0.051). No significant differences were found between the patch types.

CONCLUSION

TEA provides effective mid-term outcomes in patients with CFA disease, particularly those with IC. Although patients with CLTI show poorer survival, this appears to be driven more by systemic comorbidities than by the limb status itself. Careful preoperative assessment and holistic management of general health are essential to optimize outcomes, particularly in high-risk populations.

摘要

目的

本研究通过比较慢性肢体威胁性缺血(CLTI)患者和间歇性跛行(IC)患者,回顾性评估了日本队列中股总动脉(CFA)疾病行血栓内膜切除术(TEA)的中期结果。

材料与方法

分析了2011年至2024年间进行的63例TEA手术。主要终点集中在与手术相关的结果,如通畅率和肢体挽救情况,而总生存率作为关键的次要结果进行评估。患者分为CLTI组(n = 20)和IC组(n = 43);比较了麻醉类型、额外的血管重建、失血量、住院时间、并发症和生存率。进行多变量Cox回归分析以确定死亡率的独立预测因素。

结果

CLTI患者局部麻醉、额外血管重建(均同时进行)、失血量更大和住院时间更长的发生率更高。尽管两组技术成功率均为100%,但30天死亡率和并发症仅发生在CLTI组。Kaplan-Meier分析显示两组之间通畅率和肢体挽救率相似,而CLTI患者的生存率显著较低(P = 0.037)。多变量分析显示CLTI本身不是死亡率的独立预测因素;相反,较差的全身状况(如较高的美国麻醉医师协会分级)显示出预后较差的趋势(P = 0.051)。补片类型之间未发现显著差异。

结论

TEA为CFA疾病患者,尤其是IC患者提供了有效的中期结果。尽管CLTI患者生存率较差,但这似乎更多是由全身合并症而非肢体状况本身导致的。术前仔细评估和全面的整体健康管理对于优化结果至关重要,尤其是在高危人群中。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5e6/12311306/85e80086bf6c/vsi-41-18-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5e6/12311306/85e80086bf6c/vsi-41-18-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5e6/12311306/85e80086bf6c/vsi-41-18-f1.jpg

相似文献

1
Clinical Outcomes of Common Femoral Thromboendarterectomy for Lower-Extremity Arterial Disease: Differences Between Chronic Limb-Threatening Ischemia and Intermittent Claudication.下肢动脉疾病股总动脉血栓内膜切除术的临床结果:慢性肢体威胁性缺血与间歇性跛行之间的差异
Vasc Specialist Int. 2025 Jul 31;41:18. doi: 10.5758/vsi.250027.
2
The Relationship Between the Global Limb Anatomic Staging System and Midterm Outcomes of Subintimal Angioplasty of Superficial Femoral Artery Atherosclerotic Disease in Chronic Limb Threatening Ischemia.全球肢体解剖分期系统与慢性肢体威胁性缺血中股浅动脉粥样硬化疾病内膜下血管成形术中期结果的关系
J Endovasc Ther. 2023 Sep 27:15266028231200466. doi: 10.1177/15266028231200466.
3
Impact of congestive heart failure on mid-term outcomes after lower extremity revascularization for peripheral artery disease.充血性心力衰竭对下肢外周动脉疾病血运重建术后中期结局的影响。
J Vasc Surg. 2025 May 20. doi: 10.1016/j.jvs.2025.05.027.
4
Bypass surgery for chronic lower limb ischaemia.慢性下肢缺血的搭桥手术。
Cochrane Database Syst Rev. 2017 Apr 3;4(4):CD002000. doi: 10.1002/14651858.CD002000.pub3.
5
Twelve-Month Outcomes of Intravascular Lithotripsy for Treatment of Calcified Popliteal and Infrapopliteal Lesions in Patients With Chronic Limb-Threatening Ischemia.血管内碎石术治疗慢性肢体威胁性缺血患者钙化腘动脉和腘下病变的12个月结果
J Endovasc Ther. 2023 Oct 18:15266028231205421. doi: 10.1177/15266028231205421.
6
Duplex ultrasound for surveillance of lower limb revascularisation.下肢血运重建后监测的双功能超声检查。
Cochrane Database Syst Rev. 2023 Jul 20;7(7):CD013852. doi: 10.1002/14651858.CD013852.pub2.
7
Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.静脉注射硫酸镁和索他洛尔预防冠状动脉搭桥术后房颤:系统评价与经济学评估
Health Technol Assess. 2008 Jun;12(28):iii-iv, ix-95. doi: 10.3310/hta12280.
8
Textbook outcomes after revascularization for chronic limb-threatening ischemia remain rare.慢性肢体威胁性缺血血管重建术后达到教科书所述的结果仍然很少见。
J Vasc Surg. 2025 Aug;82(2):536-548.e5. doi: 10.1016/j.jvs.2025.03.202. Epub 2025 Apr 2.
9
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
10
Clinical outcomes in patients with chronic limb-threatening ischemia after femoropopliteal intervention with a drug-coated balloon or stenting.股腘动脉介入治疗后使用药物涂层球囊或支架的慢性肢体威胁性缺血患者的临床结局
J Vasc Surg. 2025 Jul;82(1):164-172.e2. doi: 10.1016/j.jvs.2025.02.010. Epub 2025 Feb 18.

本文引用的文献

1
Morbidity and mortality of common femoral endarterectomy.常见股总动脉内膜切除术的发病率和死亡率。
J Vasc Surg. 2024 Jul;80(1):199-203. doi: 10.1016/j.jvs.2024.01.211. Epub 2024 Feb 14.
2
Tissue-engineered and autologous pericardium in congenital heart surgery: comparative histopathological study of human vascular explants.先天性心脏病手术中组织工程心包与自体心包:人体血管外植体的比较组织病理学研究
Eur J Cardiothorac Surg. 2024 Mar 1;65(3). doi: 10.1093/ejcts/ezae027.
3
Comparison of Clinical Outcomes in Patients Undergoing Common Femoral Thromboendarterectomy With or Without Patch Angioplasty.
比较行普通股总动脉血栓内膜切除术患者是否应用补片成形术的临床转归。
Eur J Vasc Endovasc Surg. 2023 Jun;65(6):870-877. doi: 10.1016/j.ejvs.2023.03.034. Epub 2023 Mar 24.
4
Long-Term Outcomes following Common Femoral Endarterectomy.股总动脉内膜切除术的长期预后
J Clin Med. 2022 Nov 21;11(22):6873. doi: 10.3390/jcm11226873.
5
Open Surgical Thrombendarterectomy Versus Endovascular Treatment in Occlusive Processes of the Femoral Artery Bifurcation.开放手术血栓内膜切除术与腔内治疗股动脉分叉闭塞性病变的比较。
Dtsch Arztebl Int. 2022 Nov 25;119(47):803-809. doi: 10.3238/arztebl.m2022.0331.
6
Bovine pericardial patch: A good alternative in femoral angioplasty.牛心包补片:股动脉血管成形术的良好替代物。
J Vasc Surg. 2023 Jan;77(1):225-230. doi: 10.1016/j.jvs.2022.08.010. Epub 2022 Aug 18.
7
1-Year Outcomes of Thromboendarterectomy vs Endovascular Therapy for Common Femoral Artery Lesions: CAULIFLOWER Study Results.股总动脉病变行血栓内膜切除术与血管内治疗的1年结局:CAULIFLOWER研究结果
JACC Cardiovasc Interv. 2022 Jul 25;15(14):1453-1463. doi: 10.1016/j.jcin.2022.03.010. Epub 2022 Jun 29.
8
Three-year outcome of directional atherectomy and drug coated balloon for the treatment of common femoral artery steno-occlusive lesions.经皮定向斑块旋切术联合药物涂层球囊治疗股总动脉狭窄闭塞性病变的 3 年临床疗效
Catheter Cardiovasc Interv. 2022 Mar;99(4):1310-1316. doi: 10.1002/ccd.30020. Epub 2021 Nov 14.
9
Short and long-term outcome after common femoral artery hybrid procedure in patients with intermittent claudication and chronic limb threatening ischemia.股浅动脉杂交术治疗间歇性跛行和慢性肢体威胁性缺血患者的近期和远期疗效。
Vasa. 2021 Sep;50(5):363-371. doi: 10.1024/0301-1526/a000954. Epub 2021 May 11.
10
Global vascular guidelines on the management of chronic limb-threatening ischemia.全球血管指南:慢性肢体威胁性缺血的管理。
J Vasc Surg. 2019 Jun;69(6S):3S-125S.e40. doi: 10.1016/j.jvs.2019.02.016. Epub 2019 May 28.